Vuzix Corp - Quarter Report: 2010 September (Form 10-Q)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

þ	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended September 30, 2010

¨	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number 000-53846

VUZIX CORPORATION

(Exact name of registrant as specified in its charter)

Delaware		04-3392453
State or other jurisdiction of incorporation or organization		(I.R.S. Employer Identification No.)

75 Town Centre Drive Rochester, New York		14623
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: (585) 359-5900

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to filing requirements for the past 90 days. Yes þ No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ¨ No ¨

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer”, “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ¨

Accelerated filer ¨

Non-accelerated filer ¨

(Do not check if a smaller

reporting company)

Smaller reporting company þ

Indicate by check mark whether the registrant is a shell company (as defined in rule 12b-2 of the Exchange Act). Yes ¨ No þ

As of November 12, 2010, there were 263,600,274 shares of the registrant’s common stock outstanding.

Vuzix Corporation

INDEX

		Page No.

Part I – Financial Information

Item 1.	Consolidated Financial Statements (Unaudited):	3

	Consolidated Balance Sheets as of September 30, 2010 and December 31, 2009 (Unaudited)	3

	Consolidated Statements of Operations for the Three and Nine Months Ended September 30, 2010 and 2009 (Unaudited)	4

	Consolidated Statement of Cash Flows for the Nine Months Ended September 30, 2010 and 2009 (Unaudited)	5

	Notes to the Unaudited Condensed Consolidated Financial Statements	6

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	11

Item 3.	Quantitative and Qualitative Disclosures About Market Risk	21

Item 4.	Controls and Procedures	21

Part II – Other Information

Item 1.	Legal Proceedings	21

Item 1A.	Risk Factors	21

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	21

Item 3.	Defaults Upon Senior Securities	21

Item 4.	Reserved	21

Item 5.	Other Information	21

Item 6.	Exhibits	22

Signatures		23

Part 1: FINANCIAL INFORMATION

Item 1:

Condensed Consolidated Financial Statements

VUZIX CORPORATION

CONSOLIDATED BALANCE SHEETS

(Unaudited)

	September 30,			December 31,
	2010			2009
Current Assets
Cash and Cash Equivalents	$	349,092		$	2,500,523
Accounts Receivable, Net		641,646			1,446,750
Inventories		2,987,644			2,959,636
Prepaid Expenses and Other Assets		46,040			41,192

Total Current Assets		4,024,422			6,948,101

Tooling and Equipment, Net		589,987			701,368
Patents and Trademarks, Net		780,313			759,356

Total Assets	$	5,394,722		$	8,408,825

Current Liabilities
Accounts Payable	$	3,752,170		$	3,936,914
Lines of Credit		212,500			178,107
Current Portion of Long-term Debt		215,500			715,500
Notes Payable		175,000			246,417
Current Portion of Capital Leases		102,318			100,661
Current Portion of Deferred Trade Payable		1,746,500			—
Customer Deposits		1,309,361			170,671
Accrued Interest		314,466			154,016
Accrued Expenses		495,911			403,558

Total Current Liabilities		8,323,726			5,905,844

Long-Term Liabilities
Accrued Compensation		595,096			445,096
Long Term Portion of Long-Term Debt		209,208			209,208
Long Term Portion of Trade Payables		—			1,746,500
Long Term Portion of Capital Leases		93,456			94,176
Accrued Interest		392,543			338,226

Total Long-Term Liabilities		1,290,303			2,833,206

Total Liabilities		9,614,029			8,739,050

Stockholders’ Equity
Preferred Stock — $.001 Par Value, 500,000 Shares Authorized; none issued		—			—
Common Stock — $.001 Par Value, 700,000,000 Shares Authorized; 263,600,274 Shares Issued and Outstanding September 30 and December 31		263,600			263,600
Additional Paid-in Capital		17,857,907			17,665,941
Accumulated (Deficit)		(22,113,478	)		(18,032,430	)
Subscriptions Receivable		(227,336	)		(227,336	)

Total Stockholders’ Equity		(4,219,307	)		(330,225	)

Total Liabilities and Stockholders’ Equity	$	5,394,722		$	8,408,825

The accompanying notes are an integral part of these condensed consolidated financial statements.

VUZIX CORPORATION

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

	For Three Months						For Nine Months
	Ended September 30,						Ended September 30,
	2010			2009			2010			2009
	(Unaudited)			(Unaudited)			(Unaudited)			(Unaudited)

Sales of Products	$	2,246,797		$	2,513,685			6,086,439			6,964,002
Sales of Engineering Services		478,942			324,776			616,619			956,546

Total Sales		2,725,739			2,838,461			6,703,058			7,920,548

Cost of Sales — Products		1,652,078			1,680,996			4,599,169			4,550,045
Cost of Sales — Engineering Services		292,952			165,636			370,670			518,448

Total Cost of Sales		1,945,030			1,846,632			4,969,839			5,068,493

Gross Profit		780,709			991,829			1,733,219			2,852,055
Operating Expenses:
Research and Development		526,541			645,172			1,478,405			1,591,070
Selling and Marketing		489,607			509,788			1,624,859			1,485,828
General and Administrative		707,501			548,931			2,045,409			1,539,660
Depreciation and Amortization		119,659			101,256			343,915			407,600

Total Operating Expenses		1,843,308			1,805,147			5,492,588			5,024,158

Loss from Operations		(1,062,599	)		(813,318	)		(3,759,369	)		(2,172,103	)

Other Income (Expense)
Interest and Other (Expense) Income		2			3			746			63
Foreign Exchange Gain (Loss)		(15,099	)		(7,065	)		(24,614	)		(12,034	)
Interest Expenses		(106,934	)		(67,547	)		(290,212	)		(189,643	)

Total Other Income (Expense)		(122,031	)		(74,609	)		(314,080	)		(201,614	)

Loss Before Provision for Income Taxes		(1,184,630	)		(887,927	)		(4,073,449	)		(2,373,717	)
Provision (Benefit) for Income Taxes		2,335			(31,516	)		7,599			(29,740	)

Net Loss		(1,186,965	)	$	(856,411	)		(4,081,048	)		(2,343,977	)

Basic and Diluted Loss per Share	$	(0.0045	)	$	(0.0040	)		(0.0155	)		(0.0110	)
Weighted-average Shares Outstanding — Basic and Diluted		263,600,274			220,268,927			263,600,274			220,046,075

The accompanying notes are an integral part of these condensed consolidated financial statements.

VUZIX CORPORATION

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

	Nine Months Ended
	September 30,
	2010			2009

Cash Flows from Operating Activities
Net Loss	$	(4,081,048	)	$	(2,343,977	)
Non-Cash Adjustments
Depreciation and Amortization		343,915			407,600
Stock-Based Compensation Expense		186,066			144,301
Warrants Issued for Credit Line		5,901			—
(Increase) Decrease in Operating Assets
Accounts Receivable		805,104			592,935
Inventories		(28,008	)		165,233
Prepaid Expenses and Other Assets		(4,848	)		121,210
Increase (Decrease) in Operating Liabilities
Accounts Payable		(184,745	)		(157,755	)
Accrued Expenses		93,260			217,301
Customer Deposits		1,138,690			(12,988	)
Income Taxes Payable		(907	)		(32,343	)
Accrued Compensation		150,000			—
Accrued Interest		214,767			65,057

Net Cash Flows Used in Operating Activities		(1,361,853	)		(833,426	)

Cash Flows from Investing Activities
Purchases of Tooling and Equipment		(93,230	)		(164,631	)
Investments in Patents and Trademarks		(73,733	)		(86,165	)

Net Cash Used in Investing Activities		(166,963	)		(250,796	)

Cash Flows from Financing Activities
Net Change in Lines of Credit		34,393			(18,000	)
Issuance of Common Stock		—			300,000
Repayment of Capital Leases		(85,591	)		(97,245	)
Repayment of Notes Payable		(746,417	)		—
Direct IPO Associated Costs		—			(137,531	)
Proceeds from Notes Payable		175,000			200,000
Proceeds from Long-Term Debt		—			120,500
Forgiveness of Subscription Receivable		—			81,046
Repurchase of Fractional Shares		—			(2	)

Net Cash Flows (Used)Provided by Financing Activities		(622,615	)		448,768

Net Increase (Decrease) in Cash and Cash Equivalents		(2,151,431	)		(635,454	)
Cash and Cash Equivalents — Beginning of Year		2,500,523			818,719

Cash and Cash Equivalents — End of Period	$	349,092		$	183,265

Supplemental Disclosures
Interest Paid		75,455			124,586
Income Tax Credit (Refund)		—			(164,214	)
Income Taxes Paid		8,506			40,596

Non-Cash Investing Transactions
Equipment Acquired Under Capital Lease		86,528			15,096
Dividends Declared but Not Paid		—			75,825

The accompanying notes are an integral part of these condensed consolidated financial statements.

VUZIX CORPORATION AND SUBSIDIARY

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Note 1 — Basis of Presentation

The accompanying unaudited Consolidated Financial Statements of Vuzix Corporation and Subsidiary (“the Company") have been prepared in accordance with generally accepted accounting principles in the United States of America for interim financial information (“GAAP”) and with the instructions to Form 10-Q and Article 8 of Regulation S-X of the Securities and Exchange Commission. Accordingly, the Consolidated Financial Statements do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. The accompanying Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements of the Company as of December 31, 2009, as reported in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission.

The results of the Company’s operations for any interim period are not necessarily indicative of the results of the Company’s operations for any other interim period or for a full fiscal year.

Note 2 — Liquidity and Going Concern Issues

The Company’s independent registered public accounting firm’s report issued on the consolidated financial statements for the year ended December 31, 2009 included an explanatory paragraph describing the existence of conditions that raise substantial doubt about the Company’s ability to continue as a going concern, including continued operating losses and the potential inability to pay currently due debts. The Company incurred a net loss of $4,081,048 for the nine months ended September 30, 2010 and has an accumulated deficit of $22,113,478 as of September 30, 2010. The Company’s losses in the first nine months of 2010 as well as in the years 2009 and 2008 have had a significant negative impact on the Company’s financial position and liquidity.

The Company’s cash requirements are primarily for funding operating losses, working capital, research, principal and interest payments on debt obligations, and capital expenditures. Historically, these cash needs have been met by borrowings of notes and convertible debt and the sales of securities. In this regard, management is attempting to raise additional funds through loans and additional sales of its common stock. However, there is no assurance that the Company will be successful in raising additional capital on favorable terms or at all.

The Company’s business plan for the remainder of fiscal year 2010 is based on maintaining tight control over selling, general and administrative expenses, streamlining operating expenses where possible, reducing research and development costs with a focus on shorter term development horizons, and focusing on sales of products with higher margins and lower overall working capital requirements to increase gross margin. The business plan for the remainder of 2010 projects a reduction in cash operating losses based on the Company’s existing open defense sales orders of $5.7M and the seasonal fall increase in demand for its consumer products, but the Company does not expect that it will be profitable for its fiscal year ending December 31, 2010. Moreover, there can be no assurance that the Company will achieve the sales, margins and further cost reductions to improve cash flow as contemplated in its business plan to allow it to operate its business. If the Company were to incur significant unplanned cash outlays, it would become necessary for the Company to obtain sources of capital or make further cost cuts to fund its operations in addition to those currently anticipated.

These factors raise substantial doubt about the ability of the Company to continue as a going concern. The attached consolidated financial statements do not include any adjustments relating to the recoverability and classification of asset carrying amounts or the amount of and classification of liabilities that may result should the Company be unable to continue as a going concern.

Note 3 — Inventories, Net

Inventories are stated at the lower of cost (determined on the first-in, first-out or specific identification method) or market and consisted of the following as at September 30, 2010 and December 31, 2009:

	September 30, 2010		December 31, 2009

Purchased Parts and Components	$	2,225,027	$	1,594,233
Work in Process		402,430		872,003
Finished Goods		360,187		493,400

Net	$	2,987,644	$	2,959,636

Note 4 — Accrued Expenses

Accrued expenses consisted of the following:

	September 30, 2010		December 31, 2009

Accrued Wages and Related Costs	$	128,232	$	64,529
Accrued Professional Services		78,500		52,000
Accrued Warranty Obligations		279,281		258,476
Income Taxes Payable		2,685		3,592
Other Accrued Expenses		7,213		24,961

Total	$	495,911	$	403,558

The Company has warranty obligations in connection with the sale of certain of its products. The warranty period for its products is generally one year except in certain European countries where it is two years. The costs incurred to provide for these warranty obligations are estimated and recorded as an accrued liability at the time of sale. The Company estimates its future warranty costs based on product-based historical performance rates and related costs to repair. The changes in the Company’s accrued warranty obligations for the three and nine months ended September 30, 2010 and 2009 were as follows:

	2010			2009

Accrued Warranty Obligations, January 1	$	258,476		$	106,865
Actual Warranty Expense		(93,463	)		(33,416	)
Net Warranty Provisions		109,169			30,107

Accrued Warranty Obligations, March 31	$	274,182		$	103,556
Actual Warranty Expense		(41,670	)		(31,841	)
Net Warranty Provisions		42,108			54,541
Accrued Warranty Obligations, June 30	$	274,620		$	126,256
Actual Warranty Expense		(83,384	)		(35,792	)
Net Warranty Provisions		88,045			65,599
Accrued Warranty Obligations, September 30	$	279,281		$	156,063

Note 5 – Earnings (Loss) Per Share

Basic earnings (loss) per share is computed by dividing net income or loss by the weighted average number of common shares outstanding for the period. Due to the net loss incurred in the three and the nine months ended September 30, 2010 and 2009, the assumed exercise of stock options and warrants and the conversion of debt are anti-dilutive, therefore basic and diluted loss per share are the same for both periods.

Note 6 — Accrued Compensation

Accrued compensation represents amounts owed to officers of the Company for services. The principal is not subject to a fixed repayment schedule, and interest on the outstanding balances is payable at 8% per annum, compounding annually from and after the completion of the Company’s initial public offering. $50,000 in compensation was accrued for the three months ended September 30, 2010 and the cumulative accrual for the nine months ended September 30, 2010 was $150,000.

Note 7 — Current Portion of Deferred Trade Payable

Long-term trade payable represented amounts owed to two suppliers of the Company for component purchases in 2009. Interest on the outstanding balances is payable at 10% per annum. The principal amount of $1,746,500 is due and payable together with accrued interest on January 15, 2011. The deferred trade payables are secured by all of the assets of the Company. In the event the Company consummates an equity financing that results in gross proceeds of at least US$2,000,000 then the Company must, subject to regulatory approvals, apply not less than 50% of the proceeds from such equity financing to the prompt payment of the deferred trade payables.

Note 8 — Notes Payable

Notes payable of $175,000 represent amounts borrowed from two individual lenders in April, May and September 2010. These notes are secured by all of the assets of the Company and bear interest at 18% per annum. The note balances along with accrued interest are due on November 30, 2010.

Note 9 — Customer Deposits

Customer deposits represent advance payments made by customers when they place orders for customer specific defense products. These deposits range from 20 to 40% of the total order amount. These deposits are credited to the customer against product deliveries or at the completion of their order. During the three months ended September 30, 2010 no additional deposits were received.

Note 10 — Long-Term Debt

Long-term debt consisted of the following:

	September 30,		December 31,
	2010		2009

Note payable to an officer of the Company. The principal is not subject to a fixed repayment schedule, bears interest at 8% per annum and is secured by all of the assets of the Company	$	209,208	$	209,208
Loans made by an officer of the Company pursuant to an agreement between him and the Company, whereby he agreed to make loans from time to time to the Company through December 31, 2010. Interest accrues on the outstanding balance at 12%. Secured by all of the assets of the Company.		215,500		215,500
Convertible Notes payable bearing interest at 10% that are secured by all the assets of the Company		—		500,000

	$	424,708	$	924,708
Less: Amount Due Within One Year		215,500		715,500

Amount Due After One Year	$	209,208	$	209,208

Note 11 — Income Taxes

The Company’s effective income tax rate is a combination of federal, state and foreign tax rates and differs from the U.S. statutory rate due to taxes on foreign income, permanent differences including tax-exempt interest, and the resolution of tax uncertainties, offset by a valuation allowance against U.S. deferred income tax assets.

At December 31, 2009, the Company had unrecognized tax benefits totaling $3,659,000, which would have a favorable impact on the Company’s provision (benefit), if recognized.

In the three and nine-month periods ended September 30, 2010 and 2009, the Company generated federal and state net operating losses for income tax purposes. These federal and state net operating loss carry forwards total approximately $18,700,000 at September 30, 2010 and begin to expire in 2018, if not utilized. Of the Company’s tax credit carry forwards, $1,209,000 expires between 2017 and 2018, if not utilized.

The Company’s income tax returns have not been examined by the Internal Revenue Service and are subject to examination for three years after the date of filing. State income tax returns are generally subject to examination for a period of three to five years after filing of the respective return. The state impact of any federal changes remains subject to examination by various states for a period of up to one year after formal notification to the states.

Note 12 — Stock Warrants and Agent Options

A summary of the various changes in warrants during the nine-month period ended September 30, 2010 is as follows.

	Number of Shares

Warrants Outstanding at December 31, 2009		19,067,194
Exercised During the Period		—
Issued During the Period		555,555
Expired During the Period		(254,600	)

Warrants Outstanding, September 30, 2010		19,368,149

The outstanding warrants as of September 30, 2010 expire from December 31, 2010 to December 31, 2015. The weighted average remaining contract term on the warrants is 2.4 years. The weighted average exercise price is $0.2506 per share.

As consideration for an expanded trade credit line from a key supplier, the Company in May 2010 issued the key supplier a warrant to purchase 555,555 common shares, with an exercise price of Cdn$0.12 per share. The US dollar equivalent of the exercise price based on the closing buying rate of the Bank of Canada on September 30, 2010 was US $0.116 per share. The warrants are exercisable until the earlier of (i) the later of (a) the expiration of the line of credit and (b) repayment of all advances thereunder; or (ii) May 21, 2015. The line of credit will expire and all amounts outstanding thereunder will become due and payable on May 21, 2011.

During 2009, the Company issued warrants to purchase 1,000,000 and 15,590,079 shares, respectively, of common stock to an investor in a private placement and pursuant to the Company’s initial public offering in December 2009. The exercise price of the 1,000,000 warrants was US$0.20 per share and the exercise price of the warrants issued pursuant to the Company’s initial public offering unit offering was $0.291 ($0.30 Canadian dollars) per share. As consideration for their services, the agents involved in the Company’s recent initial public offering received options to purchase 3,897,519 units, each unit consisting of one common share and one half common stock purchase warrant, at an exercise price of Cdn$0.20 per unit. The US dollar equivalent of the option exercise price based on the closing buying rate of the Bank of Canada on September 30, 2010 was US $0.194 per unit. Each whole warrant issuable upon exercise of the option entitles the holder to purchase one share of common stock at an exercise price of Cdn$0.30 per share. The US dollar equivalent of the warrant exercise price based on the closing buying rate of the Bank of Canada on September 30, 2010 was US $0.291 per share. The agent options expire on December 31, 2010 and the warrants issuable upon exercise of the options expire on December 23, 2012.

Note 13 — Stock Option Plans

A summary of stock option activity for the nine months ended September 30, 2010 is as follows.

				Weighted
	Number of			Average		Exercise Price
	Shares			Exercise Price		Range

Outstanding at December 31, 2009		15,885,578		$	0.1195	$	0.0061 – $ 0.2334
Granted		—		$	—	$	—
Exercised		—		$	—	$	—
Expired or Forfeited		(427,040	)	$	0.1739	$	0.1500 – $ 0.2334

Outstanding at September 30, 2010		15,458,538		$	0.1194	$	0.0061 – $ 0.2334

As of September 30, 2010, there were 12,855,163 options that were fully vested and exercisable at a weighted average exercise price of $0.1086 per share. The weighted average remaining contractual term on the vested options is 4.5 years.

As of September 30, 2010 there were 2,603,375 unvested options exercisable at a weighted average exercise price of $0.1648 per share. The weighted average remaining contractual term on the unvested options is 8.5 years.

No cash was received from option exercises for the three or nine months ended September 30, 2010.

Note 14 — Stock-based Compensation Expense

The table below summarizes the impact of outstanding stock options on the results of operations for the three and nine-month periods ended September 30, 2010 and 2009:

	Three Months Ended				Nine Months Ended
	September 30, 2010		September 30, 2009		September 30, 2010		September 30, 2009

Stock-based compensation expense: - - Stock Options	$	62,022	$	33,379	$	186,066	$	144,301
Income tax benefit		—		—		—		—
Net Decrease in Net Income	$	62,022	$	33,379	$	186,066	$	144,301

Per share increased in Loss Per Share:

Basic and Diluted	$	0.0002	$	0.0002	$	0.0007	$	0.0007

The weighted average fair value of option grants was calculated using the Black-Scholes-Merton option pricing method. At September 30, 2010, the Company had approximately $261,639 of unrecognized stock compensation expense, which will be recognized over a weighted average period of approximately 1.1 years.

Note 15 — Product Revenue

The following table represents the Company’s total sales classified by product category for the three and nine months ended September 30, 2010 and 2009:

	Three Months Ended				Nine Months Ended
	September 30, 2010		September 30, 2009		September 30, 2010		September 30, 2009

Consumer Video Eyewear	$	1,011,436	$	819,593	$	3,220,868	$	2,564,984
Defense Products		1,222,958		1,687,315		2,834,536		4,374,452
Engineering Services		478,942		324,776		616,619		956,546
Low Vision Products		12,043		6,777		31,035		24,566

Total	$	2,725,739	$	2,838,461	$	6,703,058	$	7,920,548

Note 16 — Subsequent Event

As consideration for increasing its existing revolving line of trade credit from $250,000 to $500,000, the Company in October 2010 issued to a key supplier a warrant to purchase 555,555 common shares, with an exercise price of Cdn$0.12 per share. The US dollar equivalent of the exercise price based on the closing buying rate of the Bank of Canada on September 30, 2010 was US $0.116 per share. The warrants are exercisable until the earlier of (i) the later of (a) the expiration of the line of credit and (b) repayment of all advances thereunder; or (ii) May 21, 2015. The line of credit will expire and all amounts outstanding thereunder will become due and payable on May 21, 2011.

Note 17 — Recent Accounting Pronouncements

In October 2009, the FASB issued authoritative guidance on revenue recognition that is effective for fiscal years beginning after June 15, 2010, with earlier adoption permitted. Under the new guidance on arrangements that include software elements, tangible products that have software components (referred to as “software-enabled devices”) that are essential to the functionality of the tangible product will no longer be within the scope of the software revenue recognition guidance, and software-enabled products will now be subject to other relevant revenue recognition guidance. Additionally, the FASB issued authoritative guidance on revenue arrangements with multiple deliverables that are outside the scope of the software revenue recognition guidance. Under the new guidance, when vendor specific objective evidence or third party evidence for deliverables in an arrangement cannot be determined, a best estimate of the selling price is required to separate deliverables and allocate arrangement consideration using the relative selling price method. The new guidance includes new disclosure requirements on how the application of the relative selling price method affects the timing and amount of revenue recognition. The Company is evaluating the extent, if any, to which this new guidance will impact its financial statements. This guidance becomes effective as of January 1, 2011.

In January 2010, the FASB issued Accounting Standards Update (“ASU”) 2010-06, “Fair Value Measurements and Disclosures” which improves disclosures about the measurement of the fair value of financial instruments including (1) the different classes of assets and liabilities measured at fair value, (2) the valuation techniques and inputs used, (3) the activity in Level 3 fair value measurements, and (4) the transfers between Levels 1, 2, and 3 of the fair value inputs hierarchy. The guidance is effective for fiscal years and interim periods ended after December 15, 2009. The adoption of the guidance did not have a material impact on the Company’s consolidated financial statements.

In April 2010, the FASB issued ASU 2010-17, “Milestone Method of Revenue Recognition”. This update provides guidance on defining a milestone under Topic 605, Revenue Recognition – Milestone Method, and determining when it may be appropriate to apply the milestone method of revenue recognition for research or development transactions. Consideration that is contingent on achievement of a milestone in its entirety may be recognized as revenue in the period in which the milestone is achieved only if the milestone is judged to meet certain criteria to be considered substantive. Milestones should be considered substantive in their entirety and may not be bifurcated. An arrangement may contain both substantive and non-substantive milestones that should be evaluated individually. ASU 2010-17 is effective on a prospective basis for milestones achieved beginning on or after June 15, 2010. Adoption of this new guidance did not have a material impact on the consolidated financial statements.

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

You should read the following discussion and analysis of financial condition and results of operations in conjunction with the financial statements and related notes appearing elsewhere in this interim report. In addition to historical information, the matters discussed in Management's Discussion and Analysis of Financial Condition and Results of Operations and elsewhere in this Form 10-Q include forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Actual results could differ materially from those discussed in the forward-looking statements.

As used in this report, unless otherwise indicated, the terms “Company,” “Vuzix” “management,” “we,” “our,” and “us” refer to Vuzix Corporation and its subsidiary.

Critical Accounting Policies and Significant Developments and Estimates

The discussion and analysis of our financial condition and results of operations are based on our financial statements and related notes appearing elsewhere in this quarterly report. The preparation of these statements in conformity with generally accepted accounting principles requires the appropriate application of certain accounting policies, many of which require us to make estimates and assumptions about future events and their impact on amounts reported in our financial statements, including the statement of operations, balance sheet, cash flow and related notes. Since future events and their impact cannot be determined with certainty, the actual results will inevitably differ from our estimates. Such differences could be material to the financial statements.

We believe that our application of accounting policies, and the estimates inherently required therein, are reasonable. These accounting policies and estimates are periodically reevaluated, and adjustments are made when facts and circumstances dictate a change. Historically, we have found our application of accounting policies to be appropriate, and actual results have not differed materially from those determined using necessary estimates.

Our accounting policies are more fully described in the notes to our financial statements included in this quarterly report and our annual report on Form 10-K for the year ended December 31, 2009. In reading our financial statements, you should be aware of the factors and trends that our management believes are important in understanding our financial performance. The critical accounting policies, judgments and estimates that we believe have the most significant effect on our financial statements are:

valuation of inventories;

carrying value of long-lived assets;

valuation of intangible assets;

revenue recognition;

product warranty;

research and development

stock-based compensation; and

income taxes.

Valuation of Inventories

Inventory is stated at the lower of cost or market, with cost determined on a first-in, first-out method. Inventory includes purchased parts and components, work in process and finished goods. Provisions for excess, obsolete or slow moving inventory are recorded after periodic evaluation of historical sales, current economic trends, forecasted sales, estimated product lifecycles and estimated inventory levels. Purchasing practices, electronic component obsolescence, accuracy of sales and production forecasts, introduction of new products, product lifecycles, product support and foreign regulations governing hazardous materials are the factors that contribute to inventory valuation risks. Exposure to inventory valuation risks is managed by maintaining safety stocks, minimum purchase lots, managing product and end-of-life issues brought on by aging components or new product introductions, and by utilizing certain inventory minimization strategies such as vendor-managed inventories. The accounting estimate related to valuation of inventories is considered a “critical accounting estimate” because it is susceptible to changes from period-to-period due to the requirement for management to make estimates relative to each of the underlying factors, ranging from purchasing, to sales, to production, to after-sale support. If actual demand, market conditions or product lifecycles differ from estimates, inventory adjustments to lower market values would result in a reduction to the carrying value of inventory, an increase in inventory write-offs and a decrease to gross margins.

Carrying Value of Long-Lived Assets

If facts and circumstances indicate that the value of a long-lived asset, including a product’s mold tooling and equipment, may be impaired, the carrying value is reviewed in accordance with FASB ASC Topic 360-10. If this review indicates that the carrying value of the asset will not be recovered as determined based on projected undiscounted cash flows related to the asset over its remaining life, the carrying value of the asset is reduced to its estimated fair value. To date, no impairment on long-lived assets has been booked. Impairment losses in the future will be dependent on a number of factors such as general economic trends and major technology advances, and thus could be significantly different than historical results.

Valuation of Intangible Assets

We perform a valuation of intangible assets when events or circumstances indicate their carrying amounts may be unrecoverable, in whole or in part. We have not treated as impaired the value of our intellectual property, such as patents and trademarks, which were valued (net of accumulated amortization) at $780,313 as of September 30, 2010, because management believes that their value is recoverable.

Revenue Recognition

Revenue from product sales is recognized in accordance with FASB ASC Topic 605, Revenue Recognition Product sales represent the majority of our revenue. We recognize revenue from these product sales when persuasive evidence of an arrangement exists, delivery has occurred or services have been provided, the sale price is fixed or determinable, and collectability is reasonably assured. Additionally, we sell our products on terms which transfer title and risk of loss at a specified location, typically shipping point. Accordingly, revenue recognition from product sales occurs when all factors are met, including transfer of title and risk of loss, which typically occurs upon shipment by us. If these conditions are not met, we will defer the revenue recognition until such time as these conditions have been satisfied. We collect and remit sales taxes in certain jurisdictions and report revenue net of any associated sales taxes. We also sell certain products through distributors who are granted limited rights of return for stock balancing against purchases made within a prior 90-day period, including price adjustments downwards on any existing inventory. The provision for product returns and price adjustments is assessed for adequacy both at the time of sale and at each quarter end and is based on recent historical experience and known customer claims.

Revenue from any engineering consulting and other services is recognized at the time the services are rendered. For our longer-term development contracts, which to date have all been firm, fixed-priced contracts, we recognize revenue on the percentage-of-completion method. Under this method income is recognized as work on contracts progresses, but estimated losses on contracts in progress are charged to operations immediately. To date, all of our longer-term development contracts have been less than one calendar year in duration. We generally submit invoices for our work under these contracts on a monthly basis. The percentage-of-completion is determined using the cost-to-cost method.

The accounting estimate related to revenue recognition is considered a “critical accounting estimate” because terms of sale can vary, and judgment is exercised in determining whether to defer revenue recognition. Such judgments may materially affect net sales for any period. Judgment is exercised within the parameters of GAAP in determining when contractual obligations are met, title and risk of loss are transferred, sales price is fixed or determinable and collectability is reasonable assured.

Product Warranty

Warranty obligations are generally incurred in connection with the sale of our products. The warranty period for these products is generally one year, but can be 24 months in certain countries if required by law. Warranty costs are accrued, to the extent that they are not recoverable from third party manufacturers, for the estimated cost to repair or replace products for the balance of the warranty periods. We provide for the costs of expected future warranty claims at the time of product shipment or over-builds to cover replacements. The adequacy of the provision is assessed each quarter end and is based on historical experience of warranty claims and costs. The costs incurred to provide for these warranty obligations are estimated and recorded as an accrued liability at the time of sale. Future warranty costs are estimated based on historical performance rates and related costs to repair given products. The accounting estimate related to product warranty is considered a “critical accounting estimate” because judgment is exercised in determining future estimated warranty costs. Should actual performance rates or repair costs differ from estimates, revision to the estimated warranty liability would be required.

Research and Development

Research and development costs, are expensed as incurred consistent with the guidance of FASB ASC Topic 730, “Research and Development,” and include employee related costs, office expenses, third party design and engineering services, and new product prototyping costs.

Stock-Based Compensation

Our board of directors approves grants to our employees of stock options to purchase our common stock. A stock compensation expense is recorded based upon the estimated fair value of the stock option at the date of grant. The accounting estimate related to stock-based compensation is considered a “critical accounting estimate” because estimates are made in calculating compensation expense including expected option lives, forfeiture rates and expected volatility. Prior to the initial public offering of our shares, the fair market value of our common stock on the date of each option grant was determined based on the most recent cash sale of common stock in an arm’s length transaction with an unrelated third party. Subsequent to the initial public offering of our common stock, the fair market value of our common stock was based upon the closing price of our common stock on the TSX Venture Exchange on the date of grant. Expected option lives are estimated using vesting terms and contractual lives. Expected forfeiture rates and volatility are calculated using historical information. Actual option lives and forfeiture rates may be different from estimates and may result in potential future adjustments which would impact the amount of stock-based compensation expense recorded in a particular period. The weighted average fair value of option grants was calculated using the Black-Scholes-Merton option pricing method.

Income Taxes

We have historically incurred domestic operating losses from both a financial reporting and tax return standpoint. Accordingly, we record deferred income tax assets and liabilities based on the estimated future tax effects of differences between the financial and tax bases of assets and liabilities based on currently enacted tax laws. A valuation allowance is established for deferred tax assets in amounts for which realization is not considered more likely than not to occur. The accounting estimate related to income taxes is considered a “critical accounting estimate” because judgment is exercised in estimating future taxable income, including prudent and feasible tax planning strategies, and in assessing the need for any valuation allowance. To date we have determined that a 100% valuation allowance is required and accordingly no amounts have been reflected in our consolidated financial statements. In the event that it should be determined that all or part of a deferred tax asset in the future is in excess of the amount currently recorded, an adjustment of the valuation allowance would increase income to be recognized in the period such determination was made.

In addition, the calculation of our tax liabilities involves dealing with uncertainties in the application of complex tax regulations. As a result we recognize liabilities for uncertain tax positions based on the two-step process. The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates that it is more likely than not that the position will be sustained on audit, including resolution of related appeals or litigation processes, if any. The second step requires us to estimate and measure the tax benefit as the largest amount that is more than 50% likely of being realized upon ultimate settlement. It is inherently difficult and subjective to estimate such amounts, as this requires us to determine the probability of various possible outcomes. We re-evaluate these uncertain tax positions on a quarterly basis. This evaluation is based on factors including, but not limited to, changes in facts or circumstances, changes in tax law, effectively settled issues under audit and new audit activity. Such a change in recognition or measurement would result in the recognition of a tax benefit or an additional charge to the tax provision in the period.

Finally, any future recorded value of our deferred tax assets will be dependent upon our ability to generate future taxable income in the jurisdictions in which we operate. These assets consist of research credit carry-forwards, capital and net operating loss carry-forwards and the future tax effect of temporary differences between balances recorded for financial statement purposes and for tax return purposes. It will require future pre-tax earnings in excess of $18,700,000 in order to fully realize the value of our unrecorded deferred tax assets. If we were to sustain future net losses, it may be necessary to record valuation allowances against such deferred tax assets in order to recognize impairments in their estimated future economic value.

Off Balance Sheet Arrangements

We do not have any off-balance sheet arrangements that have, or are reasonably likely to have, an effect on our financial condition, financial statements, revenues or expenses.

Recent Accounting Pronouncements

In October 2009, the FASB issued authoritative guidance on revenue recognition that is effective for fiscal years beginning after June 15, 2010, with earlier adoption permitted. Under the new guidance on arrangements that include software elements, tangible products that have software components (referred to as “software-enabled devices”) that are essential to the functionality of the tangible product will no longer be within the scope of the software revenue recognition guidance, and software-enabled products will now be subject to other relevant revenue recognition guidance. Additionally, the FASB issued authoritative guidance on revenue arrangements with multiple deliverables that are outside the scope of the software revenue recognition guidance. Under the new guidance, when vendor specific objective evidence or third party evidence for deliverables in an arrangement cannot be determined, a best estimate of the selling price is required to separate deliverables and allocate arrangement consideration using the relative selling price method. The new guidance includes new disclosure requirements on how the application of the relative selling price method affects the timing and amount of revenue recognition. We are evaluating the extent, if any, to which this new guidance will impact our financial statements.

In January 2010, the FASB issued Accounting Standards Update (“ASU”) 2010-06, “Fair Value Measurements and Disclosures” which improves disclosures about the measurement of the fair value of financial instruments including (1) the different classes of assets and liabilities measured at fair value, (2) the valuation techniques and inputs used, (3) the activity in Level 3 fair value measurements, and (4) the transfers between Levels 1, 2, and 3 of the fair value inputs hierarchy. The guidance is effective for fiscal years and interim periods ended after December 15, 2009. The guidance did not have a material impact on our consolidated financial statements.

Key Performance Indicators

We believe that a key indicator for our business on an annual basis is the trend for the volume of orders received from customers, especially those orders related to night-vision electronic modules. Our consumer Video Eyewear products are relatively new and historically those sales have been the greatest during our fourth quarter (October through December). We believe that current business and economic conditions have adversely affected our customers’ ability to forecast their requirements and that this causes delays in the placement of orders. Most of our consumer products customers are placing orders for product only when they have orders in hand from their customers or when they need to replenish their inventories. Accordingly, we are not able to estimate the orders that we will receive for our products with any certainty. This is especially true for our consumer products. However, we periodically receive requests for orders in amounts greater than our operations can provide due to our current working capital constraints.

Sales in the defense market are typically to prime contractors that reflect investment levels by various military branches in specific programs and projects requiring near-eye display system capabilities. The timing of defense related expenditures remains for the most part unpredictable. Our major night-vision electronics modules customers (Kopin and DRS Technologies, Inc.) are placing orders for product only when they have orders in hand from their government customer and such orders have historically been received once or sometimes twice per year. Total shipments of night vision electronics module customers in the three months ended September 30, 2010 and 2009 were $316,878 and $1,536,850, respectively. Total shipments of night vision electronics modules to customers in the nine months ended September 30, 2010 and 2009 were $469,503, and $3,736,470, respectively. Our last completed order was received in May 2009 and was complete by the end of December 2009. We received a new order in June 2010 for $3.4 million and the entire amount of $469,503 year-to-date revenues represent the initial deliveries against that order. The balance of this order is scheduled for delivery over the next four months.

Results of Operations

Comparison of Three Months Ended September 30, 2010 and September 30, 2009

Sales. Our sales were $2,725,739 for the third quarter of 2010 compared to $2,838,461 for the same period in 2009. This represents a 4.0% decrease. Our sales from defense products decreased to $1,222,958 or 44.9% of our total sales in the third quarter of 2010 compared to $1,687,315 or 59.4% of total sales in the same period of 2009, a decrease of $464,357 or 27.5%. The decrease resulted from reduced sales of night vision electronics models in the third quarter of 2010. These revenues were $316,878 for the quarter versus $1,536,850 for the same period in 2009, a 79.4% decrease. Orders for these products typically occur only once every 12 months and we completed the most recent order in the fourth quarter of 2009. A new $3.4 million order was received in June 2010. Sales of our Tac-Eye Video Eyewear, included in this revenue category increased to $727,003 for the three month period in 2010 as compared to $150,465 for the same period in 2009, a 383% increase. Sales from our engineering services programs for the third quarter of 2010 increased to $478,942 or 17.6% of total sales compared to $324,776 or 11.4% of total sales in same quarter of 2009, and an increase of $154,166 or 47.5% over the same period in 2009. We commenced work on three new programs in our third quarter, all with an expected duration of less than 9 months. Consumer Video Eyewear product sales increased to $1,011,436 or 37.1% of total sales for the third quarter of 2010 compared to $819,593 or 28.9% of our total sales for the three months ended September 30, 2009. This increase resulted from the continued expansion of our reseller network and the introduction of new products against the 2009 comparative period. Low-vision assist product sales were $12,403 or 0.5% of total sales in the third quarter of 2010 versus $6,777 or 0.2% of our total sales in the same period in 2009. We are continuing to reduce our sales and marketing activities with this product line and intend to withdraw the current model by the end of our fourth quarter. We currently intend to re-enter the market in the 2012 time frame with a new enhanced version that we believe will be better suited to the needs of this market.

Cost of Sales and Gross Margin. Gross margin decreased to $780,709 for the third quarter of 2010 from $991,829 for the same period in 2009, a decrease of $211,120 or 21.3%. As a percentage of net sales, gross margin decreased to 28.6% for the third quarter of 2010 compared to 34.9% for the same period in 2009. This decrease was the primarily the result of a higher portion of our sales coming from lower margin Consumer Video Eyewear, which represented 37.1% of total sales versus 28.9% in the prior period. In addition, a lower average sales price on our products sold in the UK and EU, which are not sold in US dollars, also had an impact. Effective July 1, 2010, we implemented a 20% increase in our suggested retail pricing in Europe to recover the lost margin we incurred due to currency swings against the US dollar. The full impact of this price increase will not be evident until the fourth quarter because of backorder fulfillment at old pricing levels.

Research and Development. Our research and development expenses decreased by $118,631 or 18.4% in the third quarter of 2010 to $526,541 compared to $645,172 in the same three-month period of 2009. Despite this decrease, our spending on research and development as a percentage of sales decreased to 19.3% for the second quarter of 2010 compared to 22.7% for the same three-month period in 2009. This decrease was due to lower staffing levels and our decreased use of external contractors for development work versus the comparable 2009 period. Research related expenses we incur under government funded engineering programs are included in costs of goods sold.

Selling and Marketing. Selling and marketing expenses were $489,607 for the third quarter of 2010 compared to $509,788 for the same period in 2009, a decrease of $20,181 or 4.0%. The lower level of advertising and tradeshow costs in the third quarter was partially offset by increased sales commissions on a larger percentage of our defense product sales and the addition of a selling effort for augmented reality educational applications.

General and Administrative. General and administrative expenses were $707,501 for the third quarter of 2010 as compared to $548,931 for the same three-month period in 2009, an increase of $158,570 or 28.9%. The higher general and administrative expenses related to increases in personnel costs, insurance, legal and accounting expenses, and new reporting and filing costs that we incur as a public company.

Depreciation and Amortization. Our depreciation and amortization expense for the third quarter of 2010 increased by $18,403, or 18.2% to $119,659, compared to $101,256 in the same period in 2009.

Other Income (Expense). Total other expenses, consisting primarily of interest expense, was $(122,031) in the third quarter of 2010 compared to $(74,609) in the same period in 2009. The increase in expenses was primarily attributable to interest costs on our increased borrowings as compared to 2009.

Provision for Income Taxes. The provision for income taxes for the third quarter of 2010 was $2,335 compared to a net credit of $(31,516) for the same period in 2009. The provision for income taxes was for franchise taxes to Delaware, our state of incorporation. Such income taxes for the third quarter ended September 30, 2010 were $2,335 and $4,136 for the comparable 2009 period. During the third quarter of 2009 we received an additional tax credit over our prior refund accruals from New York State totaling $(35,652).

Net (Loss) and (Loss) per Share. Our net loss was $(1,186,965) or $(0.0045) per share in the third quarter of 2010, a increased loss of $330,554, or 38.6%, from $(856,411) or $(0.0040) per share in the same period in 2009.

Comparison of Nine Months Ended September 30, 2010 and September 30, 2009

Sales. Our sales were $6,703,058 for the nine months ended September 30, 2010 compared to $ 7,920,548 for the same period in 2009. This represents a 15.4% decrease. Our sales from defense products decreased to $2,834,536 or 42.3% of our total sales in the first nine months of 2010 compared to $4,374,452 or 55.2% of total sales in the same period of 2009, a decrease of $1,539,916 or 35.2%. The decrease was the result of the absence of night vision electronics sales. These sales were only $469,503 in the first nine-month period of 2010 as compared to $3,736,470 in the same period in 2009. Orders for these products typically occur only once every 12 months and we had completed the most recent prior order in the fourth quarter of 2009. A new $3.4 million order was received at the end of the second quarter of 2010 and our deliveries against it total $469,503 for the nine months ended September 30, 2010. Sales of our Tac-Eye Video Eyewear products and our new night vision display module that are included in this product category increased to $2,365,034 for the nine month period in 2010 as compared to $637,982 for the same period in 2009, a 271% increase. The increase was due to new design wins and a transition to larger procurement orders from several of our customers that integrate our solutions into their defense products. Sales from our engineering services programs for the first nine months of 2010, decreased to $616,619 or 9.2% of total sales compared to $956,546 or 12.1% of total sales in same period in 2009. Consumer Video Eyewear product sales increased to $3,220,868 or 48.1% of total sales for the first nine months of 2010 compared to $2,564,984 or 32.4% of our total sales for the same nine month period of 2009. This increase resulted from the continued expansion of our reseller network and the introduction of new products. Low-vision assist sales, consisting mainly of sales of low-vision assist products, were $31,035 or 0.5% of total sales in the first nine months of 2010 versus $24,566 or 0.3% of our total sales in the same period in 2009.

Cost of Sales and Gross Margin. Gross margin decreased to $1,733,219 for the first nine months of 2010 from $2,852,055 for the same period in 2009, a decrease of $1,118,836 or 39.2%. As a percentage of net sales, gross margin decreased to 25.9% for the first nine months of 2010 compared to 36.0% for the same period in 2009. This decrease was primarily the result a higher proportion of our sales coming from lower margin Consumer Video Eyewear, which represented 48.1% of total sales, versus 32.4% in the prior period when a much larger percentage of our revenues were from higher gross margin defense products and sales and engineering services.

Research and Development. Our research and development expenses decreased by $112,655 or 7.1% in the first nine months of 2010, to $1,478,405 compared to $1,591,070 in the same period of 2009. The decrease was due to staff reductions and our decreased use of external contractors in the 2010 period versus the comparable 2009 period. Research related expenses we incur under government funded engineering programs are included in costs of goods sold.

Selling and Marketing. Selling and marketing expenses were $1,624,859 for the first nine months of 2010 compared to $1,485,828 for the same period in 2009, an increase of $139,031 or 9.4%. Increases were attributable to higher tradeshow costs related to Consumer Electronics Show in January 2010, higher sales commissions paid on defense product sales, a new sales effort for augmented reality applications and new web store development costs.

General and Administrative. General and administrative expenses were $2,045,409 for the first nine months of 2010 as compared to $1,539,660 for the same period in 2009, an increase of $505,749 or 32.8%. The higher general and administrative expenses related to increases in personnel costs, insurance, legal and accounting expenses, and new shareholder reporting and filing costs now that we are a public company.

Depreciation and Amortization. Our depreciation and amortization expense for the first nine month period of 2010 decreased by $63,685, or 15.6% to $343,915, compared to $407,600 in the same period in 2009. The decrease was related to the fact that several sets of tooling became fully depreciated in 2009.

Other Income (Expense). Total other expenses, consisting primarily of interest expense, was $(314,080) in the first nine months of 2010 compared to $(201,614) in the same period in 2009. The increase in expenses was primarily attributable to interest costs on our increased borrowings and trade credit costs as compared to 2009.

Provision for Income Taxes. The provision for income taxes for the first nine months of 2010 was $7,599 compared to a net credit of $(29,740) for the same period in 2009. The provision for income taxes was for franchise taxes to Delaware, our state of incorporation. Such income taxes for the nine months ended September 30, 2010 were $7,599 and $5,912 for the comparable 2009 period. During the third quarter of 2009 we received an additional tax credit over our prior refund accruals from New York State totaling $(35,652).

Net (Loss) and (Loss) per Share. Our net loss was $(4,081,048) or $(0.0155) per share in the first nine months of 2010, a increased loss of $1,737,071 or 74.1%, from $(2,343,977) or $(0.0110) per share in the same period in 2009.

Liquidity and Capital Resources

As of September 30, 2010, we had cash and cash equivalents of $349,092, a decrease of $2,151,431 from $2,500,523 as of December 31, 2009.

Operating Activities. Cash (used in) operating activities was $(1,361,853) for the nine months ended September 30, 2010 and $(833,426) in the same period in 2009. Changes in non-cash operating assets and liabilities were $2,183,313 for the nine months ended September 30, 2010 and $958,650 in the same period in 2009. Increases in both customer deposits of $1,138,690 and collections of accounts receivable of $805,104 were the primary net generators of cash for the nine months ended September 30, 2010.

Investing Activities. Cash (used in) investing activities was $(166,963) during the nine months ended September 30, 2010 and $(250,796) in the same period in 2009. Cash used for investing activities related primarily to the purchase of R&D lab equipment, computer software and some product tooling enhancements. The costs of registering our intellectual property rights, included in the investing activities totals described above, were $(73,733) in the first nine months of 2010 and $(86,165) in the same period in 2009.

Financing Activities. Cash (used in) financing activities was $(622,615) during the nine months ended September 30, 2010, whereas in the same period in 2009, financing activities provided $448,768. During the first nine months of 2010, after the receipt of $175,000 from the issuance of new notes payable, the primary use of cash was $(746,417) for the repayment of notes payable from the proceeds of our IPO, whereas during the same nine month period of 2009 we sold shares of our common stock in a private placement for aggregate gross proceeds of $300,000 and received $200,000 from the issuance of notes payable.

Capital Resources. As of September 30, 2010, we had a cash balance of $349,092 and no available credit under our bank lines of credit. The outstanding balances under our lines of credit as of September 30, 2010 were $212,500. Our current credit lines are with two banks and are payable on demand and secured by the personal guarantee of our President and Chief Executive Officer, Paul J. Travers. The bank credit agreements contain various restrictions on indebtedness, liens, guarantees, redemptions, mergers, acquisitions or sale of assets, loans, and transactions with any affiliates, and investments. They also prohibit us from declaring and paying cash dividends without the bank’s prior consent.

In April and May 2010, we borrowed an aggregate amount of $125,000 from two individual lenders. In September 2010 we borrowed a further $50,000 from one of these same lenders. These loans along with accrued interest are due on November 30, 2010. On May 21, 2010 we entered into an agreement with Kopin Corporation, one of our key suppliers, to provide Vuzix with a US$250,000 revolving line of credit. Additionally in October 2010 we received a further increase of $250,000 in this credit line, bringing the total trade credit line to $500,000. The line of credit will be used to purchase micro-displays used in our products. The total line of credit expxires on May 21, 2011. Advances are required to be paid 75 days after delivery of products by Kopin. Advances not paid within 30 days will carry interest from the due date at an annual rate of 12%. As additional compensation for these agreements, Kopin received warrants to purchase a total of 1,111,110 of our common shares, with an exercise price of Cdn $0.12 share. The warrants are exercisable until the earlier of the expiration of the line of credit and repayment of all advances made thereunder.

Our cash requirements are primarily for the funding of operating losses, research and development, product tooling, and working capital. Historically, we have met these requirements through capital generated from the sale and issuance of equity and convertible debt securities, from loans by individuals (including certain of our officers and shareholders) and from our revolving bank line of credit. For the nine months ended September 30, 2010 we reported an operating loss of $(4,081,048). We therefore remain dependent on outside sources of funding until our results of operations provide positive cash flows. Our independent auditors issued a going concern explanatory paragraph in their report on our financial statements for the year ended December 31, 2009. With our current level of funding, working capital deficit of $4,300,000 and ongoing losses from operations, substantial doubt exists about our ability to continue as a going concern. The consolidated financial statements contained in this report do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts and classification of liabilities that might be necessary should we be unable to continue as a going concern.

On December 24, 2009, we completed the initial public offering of shares of our common stock, which resulted in gross proceeds of $5,810,657 and net proceeds of $3,897,942 after payment of transaction expenses. At that time, our working capital deficit was approximately $4.0 million. Two of our major trade suppliers extended the due date of our trade payables to them, totaling $1,746,500, until January 15, 2011 to improve our net working capital position. We used $746,417 of the net proceeds of our initial public offering to repay outstanding indebtedness as discussed below. We used the remaining net proceeds for general corporate purposes and to finance our current operating losses.

In September 2006, we borrowed $500,000 from an individual lender and issued a convertible 12.0% promissory note in the principal amount of $500,000 in evidence of the loan. The loan principal of $500,000 was repaid in mid-January but not the accrued interest, which was $134,193 at September 30, 2010. The unpaid accrued interest along with further accrued interest was to be repaid by September 30, 2010. We and the lender agreed that we would repay the accrued interest in minimum monthly installments of $15,000 commencing in October 2010. The interest rate increased to 18.0% per annum beginning on October 1, 2010.

In October 2008, we entered into a revolving loan agreement with Paul J. Travers, our President and Chief Executive Officer, pursuant to which Mr. Travers agreed to loan us such amounts as we may request and he may agree from time to time until December 31, 2010. Interest accrues on the principal amount outstanding under the agreement at the annual rate of 12.0% and is payable on demand. As security for our obligations under the loan agreement, we granted Mr. Travers a security interest in all of our assets. The principal amount outstanding under this loan agreement is $215,500. We anticipated using some of the net proceeds of our initial public offering to repay $215,500 due under this agreement but were and have been unable to do so..

Unless otherwise noted, this discussion and analysis relates only to results from continuing operations. This discussion and analysis should be read in conjunction with the condensed consolidated financial statements, including Note 2 thereto, and the related notes appearing in our annual report on Form 10-K for the year ended December 31, 2009. We intend to take actions necessary for us to continue as a going concern, as discussed herein, and accordingly our condensed consolidated financial statements have been prepared assuming that we will continue as a going concern. The condensed consolidated financial statements do not include any adjustments that might result from our failure to continue as a going concern.

Our ability to continue as a going concern is dependent upon our ability to have sufficient cash flows to meet our obligations on a timely basis, to obtain additional financing as may be required, and ultimately to attain positive cash flow from operations. We are considering alternatives to address our cash flow situation that include raising capital through additional sale of our equity and/or debt securities. Our long-term viability as a going concern is dependent upon our ability to (i) locate sources of debt or equity funding to meet current commitments and near-term future requirements as well as fund our ongoing operating losses and (ii) ultimately generate sufficient cash flow from operations to sustain our continuing operations. Additional sales of our securities, including convertible debt obligations could result in substantial dilution of existing stockholders. There can be no assurance that our current financial position can be improved, that we can raise additional working capital, or that we can achieve positive cash flows from operations.

If we are unable to achieve profitable operations or obtain additional financing when needed, we could be required to modify our business plan in accordance with the extent of available financing and/or enter into a strategic partnership. We also may not be able to respond to competitive pressures, develop and deploy new or enhanced products or take advantage of unanticipated acquisition opportunities. Finally, we may be required to sell all or a portion of our assets or discontinue operations.

Our cash on hand as of September 30, 2010 was not sufficient to fund our anticipated cash requirements for maintaining full operations as well as commitments and payments of principal and interest on borrowings for at least the next twelve months. Our current plan for the remainder of 2010 contemplates a need for more capital to fund operating losses and maintain or grow our revenues since we are constrained by limited working capital and reduced credit lines from our key suppliers. Between December 31, 2009 and September 30, 2010, we reduced the number of our employees by 10, or 16%. We currently rely mainly upon vendor financing in managing our liquidity. As a result, if our trade creditors were to impose unfavorable terms on us, it would negatively impact our ability to obtain products and services on acceptable terms and operate our business. Such events along with a further deterioration in our working capital would adversely affect our results of operations, cash flows and financial performance.

We plan to return to our original business strategy of introducing new and improved products and engaging in expanded research and development when and if we obtain sufficient additional funding. We will be limited in our pursuit of this strategy until we have more cash available for operations. As of September 30, 2010 we had an open order book totaling $5.7 million. The majority of these orders are for deliveries of defense products, including $3.6 million in night vision display electronics and display modules, and approximately $0.3 million for our defense Tac-Eye products. These open orders also include approximately $0.6 million in new engineering programs and $1.2 million in consumer products orders. Provided that we have the continued support of our vendors and receive additional customer deposits, we believe that we will be able to perform and deliver on the majority of existing orders over the next four months.

We plan to manage our liquidity under an operational plan that contemplates, among other things:

focusing on selling higher gross margin products, which will mean a greater emphasis on defense versus consumer products;

restructuring and reengineering our organization and processes to increase efficiency and reduce our operating costs for 2010;

minimizing our capital expenditures by eliminating, delaying or curtailing discretionary and non-essential spending;

reducing the square footage we rent;

managing our working capital through better optimization of inventory levels;

reducing and deferring some research and development and delaying some planned product and new technology introductions; and

exploring our options with respect to new borrowings and equity and debt offerings.

We cannot give any assurances as to whether any of these actions can be effected on a timely basis, on satisfactory terms or maintained once initiated. Even if successful, our liquidity plan will limit certain of our operational and strategic initiatives designed to grow our business over the long term. Furthermore, if we are unable to generate sufficient cash flow from operations to service our indebtedness or otherwise fund our operations, or if we are unable to continue to restructure our outstanding debt and/or equity securities, we could be forced to file for protection under the U.S. Bankruptcy Code.

Forward Looking Statements

This quarterly report includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 (the “Exchange Act”). The Private Securities Litigation Reform Act of 1995 (the “Reform Act”) provides a “safe harbor” for forward-looking statements. Certain written and oral statements made by management of Vuzix Corporation include forward-looking statements intended to qualify for the safe harbor from liability established by the Reform Act. These statements are based on our management’s beliefs and assumptions and on information currently available to our management. Forward-looking statements include statements concerning:

Our possible or assumed future results of operations;

Our business strategies;

Our ability to attract and retain customers;

Our ability to sell additional products and services to customers;

Our cash needs and financing plans;

Our competitive position;

Our industry environment;

Our potential growth opportunities;

Expected technological advances by us or by third parties and our ability to leverage them;

The effects of future regulation; and

The effects of competition.

All statements in this quarterly report that are not historical facts are forward-looking statements. We may, in some cases, use terms such as “anticipates,” “believes,” “could,” “estimates,” “expects,” “intends,” “may,” “plans,” “potential,” “predicts,” “projects,” “should,” “will,” “would” or similar expressions that convey uncertainty of future events or outcomes to identify forward-looking statements.

The outcome of the events described in these forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performances or achievements expressed or implied by the forward-looking statements. These important factors include our financial performance and the other important factors set forth in our annual report on Form 10-K for the year ended December 31, 2009 and in other filings with the Securities and Exchange Commission.

All such forward-looking statements are subject to certain risks and uncertainties and should be evaluated in light of important risk factors. These risk factors include, but are not limited to, those that are described in “Risk Factors” under Item 1A and elsewhere in our 2009 annual report on Form 10-K and the following: business and economic conditions, rapid technological changes accompanied by frequent new product introductions, competitive pressures, dependence on key customers, inability to gauge order flows from customers, fluctuations in quarterly and annual results, the reliance on a limited number of third party suppliers, limitations of the Company’s manufacturing capacity and arrangements, the protection of the Company’s proprietary technology, the effects of pending or threatened litigation, the dependence on key personnel, changes in critical accounting estimates, potential impairments related to investments, foreign regulations, and potential material weaknesses in internal control over financial reporting. In addition, during weak or uncertain economic periods, customers’ visibility deteriorates causing delays in the placement of their orders. These factors often result in a substantial portion of the Company’s revenue being derived from orders placed within a quarter and shipped in the final month of the same quarter.

Any of these factors could cause our actual results to differ materially from its anticipated results. For a more detailed discussion of these factors, see the "Risk Factors" discussion in Item 1A in our 2009 annual report. The Company cautions readers to carefully consider such factors. Many of these factors are beyond the Company’s control. In addition, any forward-looking statements represent the Company’s estimates only as of the date they are made, and should not be relied upon as representing the Company’s estimates as of any subsequent date. While the Company may elect to update forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so, even if its estimates change.

Item 3.

Quantitative and Qualitative Disclosures about Market Risk

Not applicable

Item 4.

Controls and Procedures

Disclosure Controls and Procedures

Our management, including our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as of the end of the period covered by this quarterly report as required by Rule 13a-15 under the Securities Exchange Act of 1934 (the “Exchange Act”). Based on that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of the period covered by this quarterly report, our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Exchange Act) are effective, in all material respects, to ensure that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

Change in Internal Control over Financial Reporting

No change in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) occurred during our most recent fiscal quarter that has materially affected, or is likely to materially affect, our internal control over financial reporting.

Part II. OTHER INFORMATION

Item 1.

Legal Proceedings

There are no material legal proceedings pending to which we or any of our subsidiaries is a party or of which any of our property is subject. To our knowledge, there are no material legal proceedings to which any our directors, officers or affiliates, or any beneficial owner of more than five percent of our common stock, or any associate of any of the foregoing, is a party adverse to us or any of our subsidiaries or has a material interest adverse to us or any of our subsidiaries.

Item 1A.

Risk Factors

In addition to the other information set forth in this report and the risk factor set forth below, you should carefully consider the factors discussed in Part I, Item 1A. “Risk Factors” in our annual report on Form 10-K for the year ended December 31, 2009. The risks discussed in our 2009 annual report could materially affect our business, financial condition and future results. The risks described in our 2009 annual report are not the only risks facing us. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially and adversely affect our business, financial condition or operating results. There are no material changes to the Risk Factors described in Item 1A in our 2009 annual report.

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

We issued warrants to purchase a total of 1,111,110 common shares of Vuzix, with an exercise price of Cdn $0.12 share. The US dollar equivalent of the exercise price based on the closing exchange rate as of September 30, 2010 was $0.116. The warrants were issued as additional compensation pursuant to a credit line agreement. The warrants are exercisable until the earlier of the expiration of the line of credit or May 21, 2015.

Item 3.

Defaults Upon Senior Securities

None

Item 4.

Reserved

Item 5.

Other Information

None

Item 6.

Exhibits

Exhibit No.		Description

31.1		Certification of the Chief Executive Officer of the Registrant pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2		Certification of the Chief Financial Officer of the Registrant pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1		Certification of the Chief Executive Officer of the Registrant pursuant to 18 U.S.C. Section 1350 adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2		Certification of the Chief Financial Officer of the Registrant pursuant to 18 U.S.C. Section 1350 adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	VUZIX CORPORATION (Registrant)

Date: November 12, 2010	By:	/s/ Paul J. Travers
		Paul J. Travers
		President, Chief Executive Officer
		(Principal Executive Officer)

Date: November 12, 2010	By:	/s/ Grant Russell
		Grant Russell
		Executive Vice President and Chief Financial Officer
		(Principal Financial and Accounting Officer)